Search

everythinglearnresearchcommunity

for

Search:↓

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Testosterone therapy improved physical and social health in a male with 49,XXXXY syndrome.

People with plantar corns and calluses may have a higher chance of having metabolic syndrome.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Young Indians with premature graying often have lower levels of certain nutrients and unhealthy lifestyles.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Hormonal imbalances, not insulin resistance or dyslipidemia, may be more important in causing acne in women over 25.

Taking a probiotic supplement twice a day improved hair growth, skin hydration, and metabolic health in adults at risk of metabolic syndrome.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Most women with PCOS have insulin resistance, especially those with phenotype B.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

Young women with PCOS and no other heart risk factors have normal heart function.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Low vitamin D levels may affect ovulation and progesterone in infertile women.